
Bioorganic and Medicinal Chemistry Letters p. 3577 - 3582 (1998)
Update date:2022-08-04
Topics:
Chambers
Antognoli
Cheng
Kuperman
Liston
Marfat
Owens
Pillar
Shirley
Watson
A new series of cysLT1 receptor antagonists represented by CP-288,886 (7) and CP-265,298 (8) were developed which are equipotent to clinical cysLT1 receptor antagonists Zafirlukast (1) and Pranlukast (2).
View MoreGuangzhou PI & PI Biotech Inc. Ltd.
Contact:+86-20-81716320
Address:13th Floor, Xinbao Technology Industrial Park, No. 2 Ruixiang Road, Huangpu District, Guangzhou,Guangdong,China
Contact:86-371-63655023
Address:No.85,jinshui road,zhengzhou,China
Shanggao Ruiya Fine Chemicals Co., Ltd
Contact:+86-795-2592103
Address:Xingguang Nanlu,Shanggao County Industry Park
BAODING SINO-CHEM INDUSTRY CO.,LTD
Contact:0312-5956088
Address:NO.8 FUXING ROAD,CHINA
Huangshan Violet Biological Technology Co., Ltd
Contact:+86-559-2335676
Address:16-201 JinShanYuan,JiangNan New City,TunXi District,HuangShan City,AnHui Province,China
Doi:10.1021/ja4098803
(2013)Doi:10.1021/ja00217a003
(1988)Doi:10.1016/j.tetlet.2013.10.156
(2014)Doi:10.1021/ja056505c
(2006)Doi:10.1016/j.tet.2020.131635
(2020)Doi:10.1002/ejoc.201801318
(2018)